Amended Statement of Changes in Beneficial Ownership (4/a)
30 Giugno 2021 - 6:28PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Bonello Michael J. |
2. Issuer Name and Ticker or Trading Symbol
PRA Health Sciences, Inc.
[
PRAH
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) EVP & CFO |
(Last)
(First)
(Middle)
C/O PRA HEALTH SCIENCES, INC, 4130 PARKLAKE AVENUE, SUITE 400 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
6/15/2021 |
(Street)
RALEIGH, NC 27612
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
6/17/2021 |
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 6/16/2021 | | S(1) | | 6589 | D | $166.43 (2) | 5275 (5) | D | |
Common Stock | 6/16/2021 | | S(1) | | 600 | D | $167.47 (3) | 4675 (5) | D | |
Common Stock | 6/16/2021 | | S(1) | | 195 | D | $168.19 (4) | 4480 (5) | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
(1) | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
(2) | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.07 to $166.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3) and (4) of this Form 4. |
(3) | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.11 to $167.96, inclusive. |
(4) | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $168.11 to $168.26, inclusive. |
(5) | The number of shares reported in Column 5 reflects the number of shares beneficially owned by the reporting person as of the filing date of this Form 4, which reflects the transactions reported on the Form 4 filed by the reporting person on June 21, 2021. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Bonello Michael J. C/O PRA HEALTH SCIENCES, INC 4130 PARKLAKE AVENUE, SUITE 400 RALEIGH, NC 27612 |
|
| EVP & CFO |
|
Signatures
|
By: /s/ Christopher L. Gaenzle, by power of attorney | | 6/30/2021 |
**Signature of Reporting Person | Date |
Grafico Azioni PRA Health Sciences (NASDAQ:PRAH)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni PRA Health Sciences (NASDAQ:PRAH)
Storico
Da Set 2023 a Set 2024
Notizie in Tempo Reale relative a PRA Health Sciences Inc (NASDAQ): 0 articoli recenti
Più Pra Health Sciences, Inc. Articoli Notizie